Table2.
Beta regression analysis MLwHF and predictor variables
| MLwHF QoL Dimensions | Predictor Variables | Estimate (CI 95%) | p |
|---|---|---|---|
| Total score | Education (< 5 years) | 0.734 (0.101; 1.366) | 0.023 * |
| Education (6-12 years) | 0.589 (-0.033; 1.211) | 0.063 | |
| Education (> 12 years) | 0.755 (-0.210; 1.720) | 0.125 | |
| Monthly family income | 0.000 (0.000; 0.001) | 0.019 * | |
| NYHA II | -0.695 (-1.162; -0.229) | 0.003 ** | |
| NYHA III | -1.416 (-1.904; -0.928) | < 0.001 *** | |
| NYHA IV | -1.404 (-2.066; -0.742) | < 0.001 *** | |
| Arterial Hypertension | 0.585 (0.239; 0.931) | 0.001 *** | |
| Previous hospitalization | -0.553 (-0.898; -0.207) | 0.002 ** | |
| Anxiety symptoms | -0.593 (-0.997; -0.190) | 0.004 ** | |
| Depression symptoms | -0.402 (-0.828; 0.025) | 0.065 | |
| Current Use of Betablocker | 0.908 (0.064; 1.752) | 0.035 * | |
| Physical | Education (< 5 years) | 1.078 (0.223; 1.934) | 0.013 * |
| Education (6-12 years) | 1.077 (0.233; 1.921) | 0.012 * | |
| Education (> 12 years) | 1.369 (0.124; 2.614) | 0.031 * | |
| NYHA II | -1.087 (-1.658; -0.516) | < 0.001*** | |
| NYHA III | -1.789 (-2.411; -1.167) | < 0.001*** | |
| NYHA IV | -2.439 (-3.326; -1.552) | < 0.001*** | |
| Arterial Hypertension | 0.755 (0.307; 1.203) | 0.001 *** | |
| Previous hospitalization | -0.867 (-1.345; -0.389) | < 0.001*** | |
| Anxiety symptoms | -0.967 (-1.404; -0.529) | < 0.001*** | |
| Current Use of Betablocker | 2.018 (0.847; 3.190) | 0.001 *** | |
| Current Use of Furosemide | 0.520(0.031; 1.010) | 0.037 * | |
| Emotional | Male | 0.538 (0.145; 0.932) | 0.007 ** |
| Education (< 5 years) | 0.725 (-0.088; 1.539) | 0.080 | |
| Education (6-12 years) | 0.747 (-0.042; 1.535) | 0.063 | |
| Education (> 12 years) | 1.135 (-0.099; 2.369) | 0.071 | |
| Ischemic etiology | 0.561 (0.132; 0.990) | 0.010 ** | |
| NYHA II | -0.229 (-0.78; 0.322) | 0.416 | |
| NYHA III | -1.234 (-1.818; -0.65) | < 0.001 *** | |
| NYHA IV | -0.727 (-1.537; 0.083) | 0.079 | |
| Previous hospitalization | -0.606 (-1.059; -0.152) | 0.009 ** | |
| Anxiety symptoms | -1.104 (-1.614; -0.595) | < 0.001*** | |
| Depression symptoms | -0.879 (-1.420; -0.338) | 0.001 *** | |
| Current Use of ACE | -1.424 (-2.312; -0.536) | 0.002 ** | |
| General | Male | -0.342 (-0.708; 0.025) | 0.068 |
| Age | 0.030(0.013; 0.047) | < 0.001*** | |
| Monthly family income | 0.001 (0.000; 0.001) | 0.001 *** | |
| NYHA II | -0.717 (-1.249; -0.184) | 0.008 ** | |
| NYHA III | -1.717 (-2.259; -1.176) | < 0.001*** | |
| NYHA IV | -1.895 (-2.627; -1.162) | < 0.001*** | |
| Current Use of Betablocker | 1.280(0.323; 2.237) | 0.009 ** |
p < 0.001;
p < 0.01;
p < 0.05.
MLwHF: Minnesota Living with Heart Failure; NYHA: New York Heart Association; ACE: angiotensin-converting enzyme inhibitor.